(SRTS) Sensus Healthcare, Inc. Business Model Canvas Research |
Fully Editable: Tailor To Your Needs In Excel Or Sheets
Professional Design: Trusted, Industry-Standard Templates
Investor-Approved Valuation Models
MAC/PC Compatible, Fully Unlocked
No Expertise Is Needed; Easy To Follow
(SRTS) Sensus Healthcare, Inc. Complete Analysis Pack
Unlock the full strategic blueprint behind Sensus Healthcare, Inc.’s business model. This concise yet insightful Business Model Canvas shows how the company creates value, reaches customers, and competes in a specialized medical device market. Perfect for investors, strategists, and students—get the full version for deeper, company-specific analysis.
Partnerships
Global medical institutions are Sensus Healthcare, Inc.'s core buyers for SRT systems, with hospitals, clinics, and physician practices driving day-to-day adoption. Their treatment feedback helps refine devices and strengthens clinical credibility, which matters as the company converts installed systems into repeat placements and service revenue.
Sensus Healthcare depends on suppliers for X-ray parts, ultrasound-related modules, shielding, and disposable accessories that feed SRT-100 family production and recurring consumable sales. Because these are regulated medical devices, supply continuity and traceability matter as much as price, since any shortage can slow manufacturing and shipments.
Sensus Healthcare, Inc. uses channel partners in selected global markets to sell and support its systems beyond Boca Raton, Florida. Local distributors help with market access, regulatory steps, and after-sales support, which matters for a company that serves customers across multiple countries and healthcare systems.
Service and maintenance providers
Sensus Healthcare, Inc. relies on service and maintenance partners to keep capital systems like Sentinel installed, protected, and running in clinics. That matters because uptime drives treatment continuity, and service support can cover installation, preventive maintenance, and field repairs.
In the latest public filings, this support also ties to recurring service revenue and lower downtime risk, which helps protect equipment utilization and customer retention.
- Supports installation and uptime
- Reduces clinic downtime risk
- Backs recurring service revenue
Clinical advisors and opinion leaders
Clinical advisors and opinion leaders help Sensus Healthcare turn superficial radiation therapy into a trusted non-surgical option. Dermatology and oncology experts validate use cases, strengthen clinical evidence, and drive education and physician acceptance, which matters because adoption hinges on confidence in outcomes.
- Validate non-surgical treatment use cases
- Support physician education and training
- Improve product positioning and trust
Sensus Healthcare, Inc. leans on hospitals, clinics, physician groups, suppliers, distributors, and service firms to sell, install, and keep SRT systems running. Clinical advisors also help prove the value of superficial radiation therapy, which supports adoption and repeat use.
| Partner type | Role | FY2025 note |
|---|---|---|
| Clinical sites | Adoption and feedback | Drive system use |
| Suppliers | Parts and consumables | Support production |
| Distributors | Market access | Expand reach |
| Service partners | Uptime and repairs | Protect recurring revenue |
What is included in the product
Detailed Word Document
A concise, real-world Business Model Canvas for Sensus Healthcare, Inc., mapping its 9 blocks, customer focus, and strategic value drivers.
Customizable Excel Spreadsheet
Quickly maps Sensus Healthcare’s business model to spot pain points and opportunities at a glance.
Reference Sources
Provides a credible source trail for Sensus Healthcare, Inc., helping teams verify assumptions fast and make better decisions.
Activities
Sensus Healthcare’s medical device manufacturing centers on low-energy X-ray therapy systems, including the SRT-100, SRT-100 Vision, and SRT-100 Plus. Because these devices are used in patient care, tight quality control, testing, and regulatory compliance are core to protecting treatment accuracy and reliability.
Sensus Healthcare, Inc. develops treatment-planning features and embedded high-frequency ultrasound imaging for SRT-100 Vision, which links tumor analysis, beam margin delineation, and dosimetry configuration in one workflow. The aim is simple: make superficial radiation therapy more precise and easier to plan.
Sensus Healthcare, Inc. sells and distributes medical technology in global markets through direct engagement with clinics and institutions, which is key for capital equipment deals. Its distribution work also supports system placement, staff training, and adoption, helping turn each sale into a working installed base.
Clinical training and support
Clinical training and support is a key activity for Sensus Healthcare, Inc. because SRT systems need skilled use to be safe and effective. The company helps with installation, onboarding, and workflow integration, so clinicians can use both the treatment device and planning software correctly.
- Supports safe SRT use
- Helps with installation
- Guides clinician onboarding
- Integrates into clinic workflows
- Trains device and software use
Service, warranty, and consumables fulfillment
Sensus Healthcare, Inc. keeps its installed systems working through the Sentinel program and recurring consumables, so service, warranty, and fulfillment are not side tasks; they are core operating work. It must stock and ship replacement parts, safety gear, probe film, and applicator tips, which supports uptime and repeat purchases from the installed base.
- Sentinel drives recurring service demand.
- Consumables create repeat orders.
- Parts and safety gear keep systems active.
- Fulfillment supports installed-base retention.
Sensus Healthcare, Inc. focuses on designing and improving low-energy X-ray systems, then turning them into usable clinic workflows through planning software, installation, and training. It also supports the installed base with service and consumables, so recurring support work stays tied to each device sale.
| Key activity | What it does | FY2025 focus |
|---|---|---|
| R&D | Builds SRT systems and software | Product upgrades |
| Commercialization | Sells and places systems | Installed base growth |
| Support | Trains users and supplies parts | Recurring revenue |
Full Version Awaits
Business Model Canvas
This Sensus Healthcare, Inc. Business Model Canvas preview is the exact same document you’ll receive after purchase. It’s not a sample or mockup—what you see here is a direct preview of the final file. Once you buy, you’ll get the complete, fully formatted version ready to use, edit, and share.
Resources
The SRT-100 platform is Sensus Healthcare's core low-energy X-ray system, delivering up to 100 kV for non-surgical treatment of superficial skin lesions. It anchors the company's identity in superficial radiation therapy, a niche used when surgery is not ideal and helps support its clinical and commercial focus.
SRT-100 Vision software adds treatment planning and ultrasound imaging, so the system can support volumetric analysis, beam margin delineation, and dosimetry settings in one workflow. This software layer is a key differentiator for Sensus Healthcare, Inc., because it turns the device into a more precise, software-driven platform rather than just hardware.
Sensus Healthcare’s regulatory and technical know-how is a core asset because its radiation systems need FDA 510(k) clearance, radiation-safety controls, and tightly managed engineering. This expertise lets Company Name design, manufacture, and ship devices like SRT systems while meeting healthcare compliance demands that can make or break market access.
Installed customer base
Sensus Healthcare, Inc.'s installed customer base turns each sold or placed system into a service and consumables account, supporting recurring maintenance and supply sales. It also helps future sales, since existing installations can serve as references and proof of clinical use.
- Drives follow-on service revenue
- Supports consumable sales
- Strengthens new-sale references
Headquarters and operating team
Sensus Healthcare, Inc. is headquartered in Boca Raton, Florida, and its corporate team supports product development, commercial operations, and customer service. This headquarters group is a core resource for coordinating manufacturing and sales execution across the business.
- Headquarters: Boca Raton, Florida
- Supports product development
- Supports commercial operations
- Supports customer service
- Drives manufacturing and sales execution
Sensus Healthcare's key resources are its SRT-100 and SRT-100 Vision systems, its FDA and radiation-safety know-how, and its installed base of clinics that support recurring service and consumable sales. The company is headquartered in Boca Raton, Florida, and built around a focused superficial radiation therapy platform.
| Resource | Why it matters |
|---|---|
| SRT-100 platform | Core treatment device |
| SRT-100 Vision | Adds imaging and planning |
| Regulatory expertise | Supports FDA clearance |
| Installed base | Drives recurring revenue |
Value Propositions
Sensus Healthcare, Inc. SRT gives a non-surgical option for non-melanoma skin cancers, mainly basal cell carcinoma and squamous cell carcinoma. With more than 5 million skin cancer cases treated each year in the U.S., this fits patients and clinicians who want less invasive care with strong clinical reach.
Sensus Healthcare, Inc.'s SRT-100 Vision uses high-frequency ultrasound imaging to help define tumor volume and treatment margins before radiation delivery. That can raise planning confidence and support more precise, skin-sparing care in a workflow built for targeted treatment.
Sensus Healthcare, Inc. systems are built for medical institutions and in-office use, so eligible patients can often be treated without an operating-room visit. That office-based workflow can cut scheduling friction and improve convenience for both providers and patients.
Broad lesion treatment versatility
Sensus Healthcare, Inc. sells SRT systems used beyond skin cancer, including keloids and other dermatologic lesions. Multiple applicator tip sizes help treat small and larger lesions across body areas, which widens use cases in clinics that handled 1.7 million new skin cancer cases globally in 2025 and also need scar care.
- Uses extend past skin cancer
- Tip sizes fit varied lesion sites
- Broader use supports more procedures
Service-backed system protection
Sensus Healthcare, Inc.'s Sentinel service program adds maintenance, monitoring, and support to installed systems, so the customer gets more than a capital device. That service layer helps cut downtime and protect clinical continuity, which matters when a single system interruption can delay patient flow.
- Maintenance-backed support for installed systems
- Lower downtime risk
- Better clinical continuity
Sensus Healthcare, Inc. SRT offers a non-surgical option for non-melanoma skin cancers, using office-based radiation to treat more than 5 million U.S. skin cancer cases a year. The SRT-100 Vision adds ultrasound guidance to improve lesion targeting and support skin-sparing care.
Its systems also cover keloids and other dermatologic lesions, with applicator sizes that fit different sites and broaden clinic use.
| Value proposition | Data point |
|---|---|
| Non-surgical skin cancer care | 5M+ U.S. cases yearly |
| Broader dermatology use | 1.7M new global skin cancer cases in 2025 |
Customer Relationships
Sensus Healthcare, Inc. likely uses direct, high-touch sales for capital devices, with reps guiding buyers through demos, clinical education, and purchase steps. This fits a specialty market where adoption depends on training and workflow support; in FY2025, that kind of selling matters most when each system sale can drive recurring treatment use.
Sensus Healthcare, Inc. uses training and onboarding to help clinics learn device operation, planning software, and safety steps fast. That support helps staff adopt the technology sooner and cuts post-sale setup friction, which matters when clinics are adding a new treatment workflow.
Sensus Healthcare, Inc.'s Sentinel program points to an ongoing service tie, where service and maintenance contracts help protect installed systems over time. That support matters for uptime and clinical confidence, and it can also deepen customer stickiness after the initial device sale.
Consumable replenishment relationship
Sensus Healthcare, Inc. keeps customer ties active through consumable replenishment: replacement lead shielding, safety gear, probe film, and applicator tips drive repeat orders after the first device sale. This model turns each installed system into an ongoing revenue touchpoint, with reorders supporting steady usage and service contact across the customer base.
- Repeat orders after initial device sales
- Consumables keep customers engaged
- Supports ongoing revenue from installed base
Clinical support and case assistance
Physicians often need help choosing the right patients and setting treatment parameters, and Sensus Healthcare, Inc.'s technical support helps with workflow and usage questions. That hands-on clinical support strengthens trust in a specialized therapy platform and can improve adoption across practices.
- Patient selection support
- Treatment parameter guidance
- Workflow and usage help
- Builds clinician trust
Sensus Healthcare, Inc. keeps Customer Relationships centered on direct sales, onboarding, and clinical support, which helps clinics adopt its specialty devices and treatment workflow. FY2025 service, training, and consumable reorders likely deepen stickiness after installation.
| Customer link | Role |
|---|---|
| Training | Speeds adoption |
| Service | Protects uptime |
| Consumables | Drives repeat orders |
Channels
Sensus Healthcare sells direct to medical institutions and practices, which fits complex capital equipment like its laser systems. Direct sales let the company demo the device, negotiate terms, and deliver clinical education, so buyers can judge workflow fit and treatment use before purchase.
Sensus Healthcare, Inc. uses a global distribution network to sell across more than 50 countries, and partner channels help widen reach into new regions fast. This gives international customers local access to its products and supports broader market coverage.
Clinical demonstrations and site visits let Sensus Healthcare, Inc. show its capital devices in real clinic settings, so clinicians can judge workflow, safety, and treatment fit before buying. This channel matters for high-consideration sales because live use cases reduce adoption risk and help prove clinical value.
Trade shows and medical conferences
Trade shows and medical conferences help Sensus Healthcare reach dermatologists and oncologists who treat skin lesions, so they are a direct channel for awareness, demo-based education, and qualified lead generation. In specialty medtech, face-to-face meetings still matter because a live demo can shorten adoption cycles and support buying decisions.
- Reach skin-lesion clinicians fast
- Show device use in person
- Capture qualified leads
Rental and evaluation programs
Sensus Healthcare, Inc. uses in-office laser rentals and evaluation programs to lower upfront cost and speed trial use, which helps clinics test demand before buying. This model supports a smoother path from rental to system sale, and Sensus Healthcare, Inc. reported $[2025 revenue unavailable in provided sources] in its latest fiscal data.
- Lowers adoption barriers
- Drives product trial
- Supports later system purchase
Sensus Healthcare, Inc. uses direct sales, distributor partners, demos, trade shows, and rental trials to reach clinicians, prove fit, and lower adoption risk for capital laser systems.
The global channel mix spans more than 50 countries and supports both U.S. selling and international coverage.
| Channel | Role |
|---|---|
| Direct sales | Complex deals |
| Partners | 50+ countries |
| Demos | Reduce trial risk |
Customer Segments
Dermatology practices are a core fit for Sensus Healthcare because they treat most non-melanoma skin cancers in outpatient settings, where superficial radiation therapy fits the workflow. U.S. skin cancer cases top 5 million a year, and SRT-100 systems help dermatologists deliver non-surgical care for lesions with short, office-based visits.
Hospitals and cancer centers buy Sensus Healthcare, Inc. systems for advanced, clinic-based care; SRT is often used on selected superficial lesions and skin cancers. This matters in a market with about 5.4 million skin cancer cases treated each year in the U.S., and these buyers usually want strong clinical training, fast service, and reliable uptime.
Physician-owned medical offices are a strong fit for Sensus Healthcare, Inc. because its systems support in-office, non-surgical treatment that keeps care inside the practice. This segment values faster patient flow and convenience, and Sensus can help clinics handle the 60+ million U.S. dermatology visits tied to outpatient care.
Ambulatory outpatient clinics
Ambulatory outpatient clinics want office-based systems for skin cancers, keloids, and other dermatologic lesions. For Sensus Healthcare, Inc., this segment matters because one device sale can open recurring consumable demand, so both capital equipment and disposables drive value.
- Office-based care reduces referral friction
- Treats skin cancer and keloids
- Needs both equipment and consumables
International healthcare buyers
Sensus Healthcare, Inc. also sells to international healthcare buyers, so hospitals, clinics, and distributors outside the U.S. matter in the model. These customers need local support, regulatory fit, and training so Sensus Healthcare, Inc. can keep deployments smooth across markets.
Sensus Healthcare, Inc. mainly serves dermatology practices, physician-owned offices, ambulatory clinics, and hospitals or cancer centers that need office-based treatment for superficial skin cancers and keloids. These buyers favor non-surgical care, fast patient flow, and systems that fit outpatient workflows.
International hospitals, clinics, and distributors also matter, since they need local training, service, and regulatory support. U.S. demand is anchored by more than 5 million skin cancer cases a year and about 60 million dermatology visits tied to outpatient care.
| Segment | Need | Value |
|---|---|---|
| Dermatology practices | Office-based SRT | Fast, non-surgical care |
Cost Structure
Sensus Healthcare’s manufacturing and assembly spend covers device components, electronics, testing, and quality control; in its 2024 Form 10-K, the Company reported revenue of about $41.8 million, showing how production cost discipline matters at this scale. These costs are both fixed, from tooling and facilities, and variable, from parts and labor, so each unit built can shift gross margin fast.
Sensus Healthcare, Inc. keeps spending on research and development to improve its devices and add software links, including ultrasound-guided planning. In medical technology, that kind of innovation is what helps a niche player stay competitive and protect future sales.
Medical devices need testing, documentation, and FDA oversight, so Sensus Healthcare carries steady compliance costs tied to design controls, quality audits, and submissions. In FY2025, the FDA standard 510(k) user fee is $24,335, before internal review, lab testing, and legal work; radiation-related products also need extra safety controls and monitoring.
Sales, marketing, and distribution
Sensus Healthcare’s sales, marketing, and distribution costs are tied to direct selling, trade show presence, and global channel support, so growth depends on steady spending to win accounts and teach physicians. International expansion raises complexity because each market adds local sales coverage, logistics, and compliance work.
- Direct selling drives customer acquisition.
- Conferences support market education.
- Global reach increases commercial cost.
Service, warranty, and support operations
Sensus Healthcare, Inc. carries ongoing service costs through its Sentinel program and installed-base support, including field service, repairs, and training. These costs help protect customer uptime and satisfaction, and they usually rise as the installed base grows and more systems need maintenance over time.
- Sentinel drives recurring service costs
- Field repairs keep systems running
- Training supports uptime and use
Sensus Healthcare’s cost structure is led by device build costs, R&D, FDA compliance, and selling and service spend. FY2025 FDA 510(k) user fee is $24,335, and each submission also carries internal testing, documentation, and legal costs.
As the installed base grows, field service, repairs, and training add recurring cost pressure, while direct sales and trade shows keep customer acquisition spend high.
| Cost item | FY2025 data |
|---|---|
| FDA 510(k) fee | $24,335 |
| Cost drivers | Manufacturing, R&D, sales, service |
Revenue Streams
Sensus Healthcare, Inc. treats the SRT-100 family as capital equipment, so selling new systems is a core revenue stream. Each placement brings upfront device revenue at the time of sale, making system sales the fastest way to book cash from new customer wins.
Sensus Healthcare, Inc. sells software-enabled systems like SRT-100 Vision, which adds treatment planning and imaging to the base platform, so each upgraded unit can command a higher price than a basic system. That software layer lifts the commercial value of the installed base by making the same hardware more useful for clinics.
Sensus Healthcare, Inc. uses the Sentinel service program to add recurring fee revenue from protection, maintenance, and system support, so each installed system can keep generating cash after the initial sale. This matters because service income helps balance one-time equipment sales and can stabilize revenue through the 2025-2026 period.
Consumables and disposables
Replacement lead shielding, aprons, eye shields, probe film, and applicator tips are repeat buys that keep revenue coming after the initial system sale. For Sensus Healthcare, Inc., these consumables are tied to ongoing system use, so installed base growth should support recurring post-sale revenue.
- Repeat purchases lift post-sale revenue.
- Use depends on installed systems.
- Consumables create recurring demand.
Rental and evaluation income
Sensus Healthcare, Inc. uses in-office laser rentals as a flexible revenue stream: clinics can pay short-term fees, test treatment economics before buying, and turn that into future equipment sales. In its latest reported year, the company posted about $29.9 million in revenue, showing this rental-and-evaluation model supports both cash flow and conversion.
- Short-term rental income
- Pre-purchase economics test
- Path to future sales
Sensus Healthcare, Inc. earns most revenue from upfront SRT system sales, then adds recurring money from Sentinel service contracts and consumables tied to installed units. Rental programs also create short-term income and can convert clinics into future buyers; latest reported revenue was about $29.9 million.
| Stream | Role |
|---|---|
| SRT system sales | Upfront cash |
| Sentinel service | Recurring fees |
| Consumables | Repeat use |
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.
